Herath C - Search Results

1

Damage to enteric neurons occurs in mice that develop fatty liver disease but not diabetes in response to a high-fat diet.

Rivera LR, Leung C, Pustovit RV, Hunne BL, Andrikopoulos S, Herath C, Testro A, Angus PW, Furness JB. Rivera LR, et al. Among authors: herath c. Neurogastroenterol Motil. 2014 Aug;26(8):1188-99. doi: 10.1111/nmo.12385. Epub 2014 Jun 23. Neurogastroenterol Motil. 2014. PMID: 24952996

2

Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease.

Leung C, Herath CB, Jia Z, Andrikopoulos S, Brown BE, Davies MJ, Rivera LR, Furness JB, Forbes JM, Angus PW. Leung C, et al. Among authors: herath cb. World J Gastroenterol. 2016 Sep 21;22(35):8026-40. doi: 10.3748/wjg.v22.i35.8026. World J Gastroenterol. 2016. PMID: 27672297 Free PMC article.

3

Dietary glycotoxins exacerbate progression of experimental fatty liver disease.

Leung C, Herath CB, Jia Z, Goodwin M, Mak KY, Watt MJ, Forbes JM, Angus PW. Leung C, et al. Among authors: herath cb. J Hepatol. 2014 Apr;60(4):832-8. doi: 10.1016/j.jhep.2013.11.033. Epub 2013 Dec 6. J Hepatol. 2014. PMID: 24316518

4

The Effects of Diabetes and High-Fat Diet on Polymodal Nociceptor and Cold Thermoreceptor Nerve Terminal Endings in the Corneal Epithelium.

Alamri AS, Brock JA, Herath CB, Rajapaksha IG, Angus PW, Ivanusic JJ. Alamri AS, et al. Invest Ophthalmol Vis Sci. 2019 Jan 2;60(1):209-217. doi: 10.1167/iovs.18-25788. Invest Ophthalmol Vis Sci. 2019. PMID: 30641549

5

Angiotensin Converting Enzyme-2 Therapy Improves Liver Fibrosis and Glycemic Control in Diabetic Mice With Fatty Liver.

Rajapaksha IG, Gunarathne LS, Asadi K, Laybutt R, Andrikopoulous S, Alexander IE, Watt MJ, Angus PW, Herath CB. Rajapaksha IG, et al. Hepatol Commun. 2022 May;6(5):1056-1072. doi: 10.1002/hep4.1884. Epub 2021 Dec 23. Hepatol Commun. 2022. PMID: 34951153 Free PMC article.

6

Current therapies and novel approaches for biliary diseases.

Rajapaksha IG, Angus PW, Herath CB. Rajapaksha IG, et al. World J Gastrointest Pathophysiol. 2019 Jan 5;10(1):1-10. doi: 10.4291/wjgp.v10.i1.1. World J Gastrointest Pathophysiol. 2019. PMID: 30622832 Free PMC article. Review.

7

Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products.

Fernando DH, Forbes JM, Angus PW, Herath CB. Fernando DH, et al. Int J Mol Sci. 2019 Oct 11;20(20):5037. doi: 10.3390/ijms20205037. Int J Mol Sci. 2019. PMID: 31614491 Free PMC article. Review.

8

Liver disease and the renin-angiotensin system: recent discoveries and clinical implications.

Lubel JS, Herath CB, Burrell LM, Angus PW. Lubel JS, et al. J Gastroenterol Hepatol. 2008 Sep;23(9):1327-38. doi: 10.1111/j.1440-1746.2008.05461.x. Epub 2008 Jun 28. J Gastroenterol Hepatol. 2008. PMID: 18557800 Free PMC article. Review.

9

Advanced glycation end products augment experimental hepatic fibrosis.

Goodwin M, Herath C, Jia Z, Leung C, Coughlan MT, Forbes J, Angus P. Goodwin M, et al. Among authors: herath c. J Gastroenterol Hepatol. 2013 Feb;28(2):369-76. doi: 10.1111/jgh.12042. J Gastroenterol Hepatol. 2013. PMID: 23173780

10

Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat.

Lubel JS, Herath CB, Tchongue J, Grace J, Jia Z, Spencer K, Casley D, Crowley P, Sievert W, Burrell LM, Angus PW. Lubel JS, et al. Clin Sci (Lond). 2009 Sep 14;117(11):375-86. doi: 10.1042/CS20080647. Clin Sci (Lond). 2009. PMID: 19371232

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters